Moderna's 2025 Revenue Outlook Reduced Amid Shipment Delays and Earnings Watch
Moderna lowered its 2025 revenue forecast due to a delay in vaccine shipments to the UK but exceeded Wall Street expectations for Q2, posting a smaller loss and higher revenue driven mainly by Covid vaccine sales, while also implementing cost cuts and workforce reductions.